Albinism-deafness syndrome

Albinism-deafness syndrome (also known as Ziprkowski-Margolis syndrome or Woolf syndrome) is a rare genetic disorder characterized by the combination of pigmentary abnormalities (albinism) and sensorineural hearing loss (deafness). The condition results from abnormal development or function of melanocytes, which are pigment-producing cells derived from the neural crest. Because melanocytes play important roles in both skin/hair/eye pigmentation and in the normal function of the inner ear (cochlea), their dysfunction leads to the dual manifestations of this syndrome. Affected individuals typically present with congenital sensorineural deafness, which is usually bilateral and severe to profound. The pigmentary features can include hypopigmentation of the skin, hair, and eyes, though the degree of pigment loss may vary. In the X-linked form described by Ziprkowski and Margolis, affected males show a piebald-like pattern of depigmentation with patches of hypopigmented and normally pigmented skin, along with white hair and profound congenital deafness. Female carriers may show partial or patchy pigmentary changes with normal or mildly affected hearing. There is currently no cure for albinism-deafness syndrome. Management is supportive and multidisciplinary, focusing on early identification and intervention for hearing loss through hearing aids or cochlear implants, speech and language therapy, and dermatologic care including sun protection for hypopigmented skin areas. Ophthalmologic monitoring may also be warranted if ocular pigment is affected. Genetic counseling is recommended for affected families to discuss recurrence risks and carrier status.

Common questions about Albinism-deafness syndrome